Scientific Sessions 2024  /  The Evolving Landscape of Diabetes and CV Outcomes  /  Will Future Trials Help Us SURPASS Our Understanding of Diabetes Management?
Logo

American Heart Association

  2
  0

Final ID:

Will Future Trials Help Us SURPASS Our Understanding of Diabetes Management?

  • Taub, Pam  ( UC San Diego , San Diego , California , United States )
  • Green, Jennifer  ( Duke University , Durham , North Carolina , United States )
  • Mcguire, Darren  ( UT Southwestern , Dallas , Texas , United States )
    • Author Disclosures:
    Pam Taub: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Consultant:Boehringer Ingelheim/Lilly:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Esperion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Novartis:Active (exists now) | Jennifer Green: DO have relevant financial relationships ; Research Funding (PI or named investigator):Boehringer Ingelheim:Active (exists now) ; Consultant:Anji:Active (exists now) ; Consultant:Valo:Active (exists now) ; Consultant:Vertex:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:Merck:Past (completed) ; Consultant:NovoNordisk:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Bluedrop:Active (exists now) ; Research Funding (PI or named investigator):Roche:Past (completed) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Lilly:Active (exists now) | Darren McGuire: DO have relevant financial relationships ; Researcher:Novo Nordisk:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:Intercept:Active (exists now) ; Consultant:Altimmune:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:NovoNordisk:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Lilly USA:Active (exists now) ; Researcher:Esperion:Past (completed) ; Researcher:AstraZeneca:Past (completed) ; Researcher:NewAmsterdam:Active (exists now) ; Researcher:Boehringer Ingelheim:Active (exists now) ; Researcher:Pfizer:Active (exists now) ; Researcher:Lilly USA:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

The Evolving Landscape of Diabetes and CV Outcomes

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
Setting the RECORD Straight on Events Leading to CV Outcomes Trials

Kaul Sanjay, Buse John

Preparing for the Future of Cardiometabolic Care: A Focus on Training Programs

Blaha Michael, Eckel Robert

More abstracts from these authors:
Patient Interview

Ndumele Chiadi, Taub Pam

Panelist - Prevention

Taub Pam

You have to be authorized to contact abstract author. Please, Login
Not Available